Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prenatal Evaluation of MicroRNA Expressions in Pregnancies with Down Syndrome

1 Jan 2016

Abstract excerpt

BACKGROUND: Currently, the data available on the utility of miRNAs in noninvasive prenatal testing is insufficient in the literature. We evaluated the expression levels of 14 miRNAs located on chromosome 21 in maternal plasma and their utility in noninvasive prenatal testing of Down Syndrome. METHOD: A total of 56 patients underwent invasive prenatal testing; 23 cases were carrying Down Syndrome affected fetuses,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Down syndrome and intellectual disability research
Share to MicroRNA in disease regulation
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27110565
DOI: 10.1155/2016/5312674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prenatal Evaluation of MicroRNA Expressions in Pregnancies with Down SyndromePMID 27110565Read ↗

Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down SyndromeSemantic proximity Read ↗

Genome-wide miRNA profiling in plasma of pregnant women with Down syndrome fetusesSemantic proximity Read ↗

Genome-wide miRNA profiling in plasma of pregnant women with down syndrome fetusesSemantic proximity Read ↗

Prenatal circulating microRNA signatures of foetal Down syndromeSemantic proximity Read ↗

Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot StudySemantic proximity Read ↗

Prenatal screening for trisomy 21: recent advances and guidelinesSemantic proximity Read ↗

Differential microRNA expression profile in blood of children with Down syndrome suggests a role in immunological dysfunctionSemantic proximity Read ↗

Second‐trimester double or triple screening for Down syndrome: A comparison of Chinese and Caucasian populationsSemantic proximity Read ↗

Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome?Semantic proximity Read ↗

Overexpression of Chromosome 21 miRNAs May Affect Mitochondrial Function in the Hearts of Down Syndrome FetusesSemantic proximity Read ↗

Identification of maternal serum microRNAs as novel non-invasive biomarkers for prenatal detection of fetal congenital heart defectsSemantic proximity Read ↗

Microarray based global transcriptome profiling reveals involvement of non-Hsa21 genes and microRNAs in molecular mechanism of Down syndrome pathogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.